Oligonucleotides for CNS Summit Europe 🌍💉

Europe's oligonucleotide sector is on the verge of a significant expansion. With a remarkable €21 million launch of Aerska and noteworthy partnerships involving Novartis & SciNeuron, Lundbeck & Contera, and Secarna & Vect-Horus, the European biopharma industry is swiftly progressing towards RNA-targeted solutions for challenging CNS diseases that were previously deemed undruggable.

To harness this dynamic landscape, the inaugural Oligonucleotides for CNS Summit Europe will gather over 60 senior leaders from the industry, creating the first European forum solely focused on CNS-targeted oligonucleotide therapeutics. This summit promises three days filled with highly technical and data-driven discussions that dive deeply into the unique challenges of CNS development. Expect insights into cutting-edge strategies for blood-brain barrier delivery, advanced in vivo and iPSC models, innovative chemistry and conjugation techniques, and pathways from preclinical findings to clinical and regulatory achievements.

Now is the perfect time to connect, collaborate, and influence the next wave of RNA-driven CNS innovation as the field embraces rapid global acceleration!

🌐 Links:

• Tickets 🎟️
• Brochure 📖

📊 Pricing:

• Conference + Pre-Conference Workshop Day + Breakfast Briefing - Drug Developer: €3946.00
• Conference + Pre-Conference Workshop Day - Drug Developer: €3397.00
• Conference Only - Drug Developer: €2499.00
• Conference + Pre-Conference Workshop Day + Breakfast Briefing - Academic: €3246.00
• Conference + Pre-Conference Workshop Day - Academic: €2797.00
• Conference Only - Academic: €2099.00
• Conference + Pre-Conference Workshop Day - Solution Provider: €4797.00
• Conference Only - Solution Provider: €3499.00

🎤 Featured Speakers:

• Farzaneh Salem, Associate Director, PB/PK Modelling, GSK
• Michal Lubas, Novel Technologies and Therapeutics Lead, Lundbeck
• Felix Schumacher, Mission Lead RNAHub, Roche
• Helene Tran, Director, Head of Antisense Oligonucleotide Therapeutic Program, Servier
• Duygu Yilmaz, Director RNA Therapeutics and Translational Science, Aerska
• Macarena Hernandez, Chief Scientific Officer, AptaTargets
• Beatriz Llamusi Troisi, Chief Scientific Officer and Co-Founder, Arthex Biotech
• Chris Shaw, Chief Scientific and Clinical Advisor, Co-Founder, AviadoBio
• Open positions for more esteemed professionals in the list...

Join us for this exclusive event dedicated to shaping the future of CNS therapeutics! 🌟